Access to Whole-Genome Sequencing for Genetic Disease Testing :Illumina and Harvard Pilgrim Health Care Kumar Jeetendra | December 20, 2020 SAN DIEGO & WELLESLEY, Mass.–(BUSINESS WIRE)– Illumina, Inc. (Nasdaq: ILMN) and Harvard Pilgrim Health Care announce a risk-sharing agreement to make whole-genome sequencing (WGS) available to certain Harvard Pilgrim members, effective January 1, 2021. The program will leverage WGS to support faster diagnoses of genetic diseases in children, potentially eliminating the long, costly diagnostic odyssey …
LifeCell and HaystackAnalytics enter into a strategic collaboration to Scale TB Whole Genome Sequencing Pan India Kumar Jeetendra | December 7, 2022 National, December 7th, 2022: LifeCell, one of India’s leading comprehensive healthcare solutions providers today announced the launch of a revolutionary genetic test – ΩTB® (pronounced as Omega TB) in partnership with HaystackAnalytics, a genomics based health-tech startup. The collaboration marks LifeCell’s foray into the genetic testing industry for TB patients. The whole genome-sequencing test, designed …
